Literature DB >> 9566307

Estrogen receptor-negative epithelial cells in mouse mammary gland development and growth.

N Zeps1, J M Bentel, J M Papadimitriou, M F D'Antuono, H J Dawkins.   

Abstract

The mouse mammary gland undergoes rapid proliferation during puberty, then cyclical proliferation and involution during adulthood within a 5-day estrous cycle. Although proliferation of mammary epithelial cells is directed by elevated serum levels of estrogen acting via the estrogen receptor (ER), the ER status of the proliferating cells remains unknown. We examined the ER expression of proliferating epithelial cell types during pubertal development and normal adult growth using simultaneous immunohistochemistry for ER and tritiated thymidine (3H-Tdr) autoradiography. These studies demonstrate that during pubertal growth (4-6 weeks) ER-negative cells comprise more than 50% of the epithelial cell populations in the terminal end buds (TEBs) and ducts. Furthermore, the majority of proliferating cells in both TEBs and ducts are ER-negative. These findings indicate that proliferation of cells within both the TEBs and the mammary ducts contribute to pubertal growth of the mammary gland and that the greater proportion of dividing cells are ER-negative. Similar patterns of cell growth were observed in the normal estrous cycle when the majority of dividing cells were ER-negative during both pro-estrous and estrous. Intensive labelling of cells with 3H-Tdr was used to identify long-lived mammary epithelial cells which retained 3H-Tdr 2 weeks following labelling (i.e., following 3 estrous cycles). Of the small number of mammary epithelial cells retaining 3H-Tdr label, most were ER-positive luminal cells and only a few were ER-negative basal cells. This study indicates that pubertal growth of the mammary gland comprises division of ER-negative cap cells and of both ER-negative and ER-positive cells in the body of the TEBs and elongating mammary ducts. Similarly, estrogen-driven proliferation of ER-negative and ER-positive luminal cells and ER-negative basal cells maintains the differentiated mammary gland in the adult mouse.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9566307     DOI: 10.1046/j.1432-0436.1998.6250221.x

Source DB:  PubMed          Journal:  Differentiation        ISSN: 0301-4681            Impact factor:   3.880


  58 in total

Review 1.  Establishing a framework for the functional mammary gland: from endocrinology to morphology.

Authors:  Russell C Hovey; Josephine F Trott; Barbara K Vonderhaar
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-01       Impact factor: 2.673

Review 2.  Epithelial stem cells: turning over new leaves.

Authors:  Cédric Blanpain; Valerie Horsley; Elaine Fuchs
Journal:  Cell       Date:  2007-02-09       Impact factor: 41.582

Review 3.  Mammary gland stem cells: more puzzles than explanations.

Authors:  Suneesh Kaimala; Swathi Bisana; Satish Kumar
Journal:  J Biosci       Date:  2012-06       Impact factor: 1.826

Review 4.  Isolation and characterization of human mammary stem cells.

Authors:  R B Clarke
Journal:  Cell Prolif       Date:  2005-12       Impact factor: 6.831

Review 5.  Progesterone regulation of stem and progenitor cells in normal and malignant breast.

Authors:  Sunshine Daddario Axlund; Carol A Sartorius
Journal:  Mol Cell Endocrinol       Date:  2011-09-16       Impact factor: 4.102

6.  The estrogen-responsive Agr2 gene regulates mammary epithelial proliferation and facilitates lobuloalveolar development.

Authors:  Suman Verma; Michael L Salmans; Mikhail Geyfman; Hong Wang; Zhengquan Yu; Zhongxian Lu; Fang Zhao; Steven M Lipkin; Bogi Andersen
Journal:  Dev Biol       Date:  2012-07-20       Impact factor: 3.582

7.  Estrogen receptors alpha and beta in the rodent mammary gland.

Authors:  S Saji; E V Jensen; S Nilsson; T Rylander; M Warner; J A Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

8.  Prospective study of breast MRI in BRCA1 and BRCA2 mutation carriers: effect of mutation status on cancer incidence.

Authors:  P Shah; M Rosen; J Stopfer; J Siegfried; R Kaltman; B Mason; K Armstrong; K L Nathanson; M Schnall; S M Domchek
Journal:  Breast Cancer Res Treat       Date:  2009-07-17       Impact factor: 4.872

Review 9.  Mammary gland development.

Authors:  Hector Macias; Lindsay Hinck
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2012 Jul-Aug       Impact factor: 5.814

10.  Selective segregation of DNA strands persists in long-label-retaining mammary cells during pregnancy.

Authors:  Brian W Booth; Corinne A Boulanger; Gilbert H Smith
Journal:  Breast Cancer Res       Date:  2008-10-24       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.